Robert Jones Recent News
INC Research Shares Edge Higher; Goldman Adds To 'Conviction Buy' List
Is 2016 The Best Year For Generic Drug Launches Since 2012?
UPDATE: Goldman Sachs Downgrades Express Scripts Holding Company
Goldman Sachs: Rite Aid Shares Poised For Further Upside
Goldman Reiterates Attractive Coverage of Drugstore Chains